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Introduction
Hypertensive disorders of pregnancy (HDP) are a major cause of maternal morbidity and mortality [1] . These generally involve hypertension related conditions occurring primarily during pregnancy or may be pre-existing and persist during and or after pregnancy [2] . Generally, HDP are said to complicate 5-10% of pregnancies and account for 10-15% of maternal deaths globally [3, 4] . Recent data suggests that the increasing incidence of HDP is partly due to an increasing trend in obesity worldwide [5, 6] .
Furthermore, the resultant worrisome maternal morbidity and mortality from HDP shows some disproportionate affection geographically, as majority of these maternal deaths are found to occur in low and middle income countries (LMICs) [7] . Preeclampsia is a HDP in which there is hypertension (systolic blood pressure (SBP) ≥140mmHg and or diastolic blood pressure (DBP) ≥90mmHg) and proteinuria occurring after 20 weeks gestation, measured on two different occasions at least 4 to 6hours apart in women previously known to be normotensive [8, 9] . In severe preeclampsia, SBP (DBP) is ≥160 (110) mmHg in the presence of proteinuria.
When convulsion occurs in the presence of these features, the condition is known as eclampsia [3] . Amongst others, preeclampsia is known to be a disorder of nulliparity, but multi parous pregnant women with new partners have been shown to have a similar elevated risk for development of preeclampsia like nulliparous women [10] . A study in northern Cameroon found teenage status, illiteracy, nulliparity and family or personal history of hypertension as risk factors for HDP [11] . It should be noted that the adverse effects of preeclampsia and eclampsia are not only limited to the mother but also to the foetus with several complications ranging from intra-uterine growth restriction to intra-uterine foetal death [12] . Several theories exist on the pathogenesis of preeclampsia, but at present, it is suggested that the placenta is the primary agent in the development of preeclampsia, hence, removal of the placenta (by termination of the pregnancy is the sole method of treating the condition [13] . Studies continue to suggest the increasing burden of HDP around the world making it a growing public health problem [1, 14] . Currently, data on risk profiles and outcome of preeclampsia and eclampsia are limited in Cameroon. We thus set out to describe the trends in admission, clinical profiles and outcomes of women admitted to ICU for preeclampsia and eclampsia in Douala General Hospital, Cameroon. Logistic regressions were used to investigate factors associated with mortality. Statistical significance was considered at p < 0.05.
Methods

Ethical Considerations
Ethical and administrative approval was obtained from the Ethics committee of the Douala General Hospital. Being a retrospective study, written informed consent was not required but confidentiality of patient records was also maintained.
Results
General Characteristics of Study population
In all, 74 women were admitted to the ICU during the study period (72.5% eclampsia and 27.5% preeclampsia). The overall mean age and mean gestational age of study participants was 30. 
Complications and Outcome of patients
Overall median length of hospital stay was 3 (1-10) days and mortality rate was 24.3%. While acute kidney injury (AKI), acute pulmonary oedema (APO) and HELLP syndrome were more common in patients with preeclampsia, (70.0% vs 51.1%, 33.3% vs 12.5% and 60.0% vs 41.2%) respectively, placenta abruptio, cerebrovascular accidents were common in patients with eclampsia (4.2% vs 0.0%, 8.3% vs 0.0%) respectively. Visual problems were more common in patients with eclampsia (p=0.01), most of whom had assisted ventilation, poorer GCS and more severe leukocytosis Moreover, the rising burden of CVDs and hypertension in SSA cannot be overemphasized. Clinical profiles suggest that patients present late with severe complications among which included AKI, visual problems, HELLP syndrome, acute heart failure with pulmonary oedema and even stroke. Some of these complications like AKI are predictors of fatal maternal outcome [19] . Other studies Page number not for citation purposes 4 suggest low rates of patients with AKI [1] with current estimates in developed countries as low as 1-2.8% [20] . In developing countries, the incidence of renal failure in HDP is higher with values as high as 36% [21] . In our study, AKI was present in up to 66.7% of cases, further re-iterating the possible late presentation to hospital.
Contrary to Seyom and colleagues who reported low rate of cases with renal failure, but rather more frequent was retroplacental haematoma [1] . Acute Pulmonary Oedema was the only predictor of mortality in our study. This was contrary to other reports, where, no antenatal care, high DBP, grand multiparity, high creatinine levels were predictors of maternal death [2, 3, 22] .
Overall mortality rate from our study was high (24.3%). This was similar to reports from Ghana [23] and Nigeria [24] , though much higher than reported in Ethiopia, where eclampsia related maternal deaths were 11.6% [2] . However, our findings are much lower than reported in a population based study in South Africa which had rates as high as 57% [25] and from India with 67% [26] . We suggest that the high rate of complications resulted in high mortality in our study. Even though this mortality was stable across years, this was probably due to the increase in personnel which probably resulted in better management. The extent of complications overemphasizes on the need of a multidisciplinary team for management, including nephrologist and ophthalmologist. Indeed AKI was found to be more frequent in patients with preeclampsia than eclampsia, which further suggests, that the nephrologist should be brought in at a very early stage so as to limit the proportion of AKI which has been shown elsewhere as a strong predictor of outcome. The retrospective design of the study however limits the study with a number of missing variables which could not obtained from patient records together with the small sample size which didn't permit further exploration of predictors of mortality. However, findings from our study deserve attention, as being the first study conducted in a key referral hospital in central Africa where there is absent data on this worrisome and leading cause of maternal mortality in the region. We recommend larger and even multi-centre national studies to further confirm our findings and investigate predictors of mortality for HDP so as to reduce the resultant maternal mortality.
Conclusion
Our findings suggest an increasing trend in ICU admissions for HDP with high but stable mortality rate. Most patients present to health facility in advanced disease states with target organ damage.
Interventions to strengthen and improve antenatal care services as well as multidisciplinary management approach may play a crucial role in reducing the burden of HDP in Cameroon.
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